Qualigen therapeutics to present at bio international convention

Carlsbad, calif., june 14, 2022 (globe newswire) -- qualigen therapeutics, inc. (nasdaq: qlgn), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for orphan drug designation, while also commercializing diagnostics, today announces that qualigen therapeutics will present a corporate overview at the bio international convention to be held on june 13 – 16, 2022 at the san diego convention center.
QLGN Ratings Summary
QLGN Quant Ranking